Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL) [NA]
Completed results from the VITAL trial evaluating vitamin D and omega-3 supplementation on bone density and bone structure have been posted.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate
Clinical trial evaluating how bone turnover markers predict outcomes during discontinuation of alendronate in osteoporosis; completed with r…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis [Phase 4]
Phase 4 trial evaluating zoledronic acid after denosumab in osteoporosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis [Phase 3]
A Phase 3 clinical trial evaluating the use of beta blockers and fracture risk in patients with primary osteoporosis is currently recruiting…
-
CLINICAL_TRIALS research · 2020-12-01Clinical Trial Update: Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis [Phase 4]
A Phase 4 clinical trial update examining how GCF levels of sclerostin and DKK-1 change in postmenopausal osteoporosis, completed with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Prostate Adenocarcinoma TransCutaneous Hormones [Phase 3]
A Phase 3 clinical trial update for TransCutaneous Hormones in prostate adenocarcinoma, with listed conditions including anemia, cardiovascu…
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation [Phase 3]
Phase 3 trial update on zoledronate for preventing bone loss in men with prostate cancer on long-term androgen deprivation; study terminated…
-
FDA approval · 2020-11-16FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories, expanding or updating the drug's regulatory statu…
-
FDA approval · 2020-10-23FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)
FDA approved a supplemental application for TYMLOS (abaloparatide) from Radius Health, Inc. The approval updates the product labeling.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients [Phase 4]
Phase 4 trial update examining changes in bone metabolic markers and bone mineral density after denosumab and/or teriparatide in Japanese os…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density [Phase 4]
Phase 4 trial evaluating romosozumab versus zoledronic acid for osteoporosis with spinal cord injury-related low bone density.
-
FDA approval · 2020-10-20FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Zoledronic acid from Hikma Pharmaceuticals USA Inc., indicating regulatory approval for the spon…
-
FDA approval · 2020-10-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for zoledronic acid from Mylan Institutional LLC under an abbreviated new drug application (ANDA), e…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: New Tools for Assessing Fracture Risk [NA]
Clinical trial update on new tools for assessing fracture risk; study terminated with results posted in 2020.
-
EMA withdrawal · 2020-09-28EMA Application withdrawn: Sondelbay (teriparatide) — Accord Healthcare S.L.U.
The EMA has withdrawn the application for Sondelbay (teriparatide) by Accord Healthcare S.L.U. for osteoporosis.
-
FDA approval · 2020-08-26FDA Approved: CALCITONIN SALMON — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for Calcitonin Salmon (Endo USA, Inc.), resulting in updated labeling for the product.
-
FDA approval · 2020-08-18FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Atelvia (risendronate sodium) from Allergan, Inc., signaling an update to the product's labeling…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients [Phase 2]
Phase 2 trial evaluating allogenic mesenchymal stem cells from umbilical cord for osteoporosis, focusing on clinical and bone density improv…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: IGF-1 and Bone Loss in Women With Anorexia Nervosa [NA]
Clinical trial update on IGF-1 and bone loss in women with anorexia nervosa; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women [Phase 3]
Phase 3 trial comparing biosimilar denosumab (Arylia) to Prolia in improving bone mineral density in osteoporotic postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating denosumab for treating osteoporosis in children has completed.
-
FDA approval · 2020-06-19FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ibandronate sodium submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2020-06-09FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA has approved a supplemental application for PROLIA (denosumab) by Amgen, Inc., amending its labeling/indications.
-
EMA withdrawal · 2020-05-19EMA Withdrawn: Osseor (strontium ranelate) — Les Laboratoires Servier
The EMA has withdrawn Osseor (strontium ranelate) from the market.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
A post-approval safety study update for bazedoxifene in the EU has completed with results posted.